BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
BHVN
Delisted
BHVN was delisted on the 3rd of October, 2022.
175 hedge funds and large institutions have $1.95B invested in Biohaven Pharmaceutical Holding Company Ltd. in 2020 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 71 increasing their positions, 47 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
21% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 43
27% less capital invested
Capital invested by funds: $2.67B → $1.95B (-$715M)
Holders
175
Holding in Top 10
10
Calls
$118M
Puts
$17.1M
Top Buyers
| 1 | +$105M | |
| 2 | +$78.7M | |
| 3 | +$53.7M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$19.8M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$18.8M |
Top Sellers
| 1 | -$24.8M | |
| 2 | -$23.9M | |
| 3 | -$13.8M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$10.2M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$9.55M |